UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (16022) 16022
Book Chapter (94) 94
Magazine Article (84) 84
Dissertation (32) 32
Newsletter (24) 24
Book / eBook (23) 23
Web Resource (21) 21
Newspaper Article (19) 19
Publication (10) 10
Journal / eJournal (6) 6
Conference Proceeding (5) 5
Government Document (4) 4
Book Review (3) 3
Poster (3) 3
Transcript (2) 2
Paper (1) 1
Reference (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (14205) 14205
science & technology (10951) 10951
life sciences & biomedicine (10733) 10733
male (7677) 7677
female (7445) 7445
community-acquired infections - microbiology (5464) 5464
middle aged (5275) 5275
aged (5138) 5138
adult (4994) 4994
infectious diseases (4624) 4624
community-acquired infections - epidemiology (4526) 4526
community-acquired infections - drug therapy (4491) 4491
pneumonia (3881) 3881
anti-bacterial agents - therapeutic use (3505) 3505
microbiology (2993) 2993
risk factors (2960) 2960
adolescent (2866) 2866
aged, 80 and over (2796) 2796
community-acquired infections - diagnosis (2725) 2725
general & internal medicine (2460) 2460
child (2379) 2379
community-acquired pneumonia (2277) 2277
child, preschool (2146) 2146
community-acquired infections (2036) 2036
retrospective studies (1973) 1973
prospective studies (1935) 1935
infant (1909) 1909
bacterial pneumonia (1756) 1756
abridged index medicus (1739) 1739
medicine, general & internal (1697) 1697
antibiotics (1639) 1639
microbial sensitivity tests (1583) 1583
health aspects (1550) 1550
treatment outcome (1503) 1503
staphylococcal infections - microbiology (1486) 1486
pneumonia, bacterial - drug therapy (1450) 1450
respiratory system (1450) 1450
community-acquired infections - mortality (1416) 1416
anti-bacterial agents - pharmacology (1415) 1415
mortality (1388) 1388
hospitalization (1373) 1373
staphylococcus aureus (1373) 1373
cross infection - microbiology (1347) 1347
immunology (1299) 1299
pharmacology & pharmacy (1288) 1288
severity of illness index (1280) 1280
young adult (1264) 1264
staphylococcal infections - epidemiology (1262) 1262
research (1259) 1259
pneumonia - drug therapy (1209) 1209
cross infection - epidemiology (1188) 1188
prognosis (1146) 1146
epidemiology (1129) 1129
incidence (1124) 1124
methicillin resistance (1094) 1094
pediatrics (1053) 1053
community-acquired infections - therapy (1048) 1048
pneumonia - diagnosis (1047) 1047
infections (1036) 1036
hospitals (1035) 1035
pneumonia, bacterial - microbiology (1023) 1023
care and treatment (1022) 1022
drug resistance, bacterial (892) 892
internal medicine (885) 885
prevalence (871) 871
staphylococcus aureus - drug effects (870) 870
analysis (828) 828
diagnosis (824) 824
community-acquired infections - prevention & control (817) 817
pneumonia, bacterial - diagnosis (814) 814
methicillin-resistant staphylococcus aureus - isolation & purification (792) 792
community-acquired infections - complications (789) 789
anti-bacterial agents - administration & dosage (778) 778
infant, newborn (772) 772
pneumonia - epidemiology (767) 767
cohort studies (763) 763
infectious disease (762) 762
critical care medicine (761) 761
public, environmental & occupational health (738) 738
children (735) 735
drug resistance (726) 726
drug resistance in microorganisms (714) 714
pneumonia - mortality (711) 711
medicine (706) 706
pneumonia - microbiology (680) 680
nosocomial infections (655) 655
staphylococcus aureus - isolation & purification (648) 648
staphylococcal infections - drug therapy (644) 644
pneumonia - therapy (632) 632
drug therapy (630) 630
streptococcus pneumoniae (625) 625
community-acquired infections - etiology (622) 622
cross infection - drug therapy (619) 619
practice guidelines as topic (619) 619
methicillin-resistant staphylococcus aureus (618) 618
research article (615) 615
time factors (612) 612
comorbidity (605) 605
bacteria (601) 601
patients (597) 597
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Online Resources - Online (20) 20
Gerstein Science - Stacks (5) 5
Scarborough Hospital - Birchmount (5) 5
Gerstein Science - Periodical Stacks (3) 3
Scarborough Hospital - General (3) 3
St. Michael's Hospital - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Gerstein Science - Bindery (1) 1
Gerstein Science - Circulation Desk (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Trillium Health Centre - Stacks (1) 1
West Park Healthcare Centre - Stacks (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (14769) 14769
Spanish (677) 677
French (507) 507
Japanese (243) 243
German (220) 220
Russian (216) 216
Portuguese (167) 167
Chinese (136) 136
Turkish (53) 53
Italian (46) 46
Dutch (33) 33
Polish (31) 31
Korean (25) 25
Ukrainian (13) 13
Hebrew (11) 11
Danish (8) 8
Hungarian (8) 8
Romanian (8) 8
Czech (7) 7
Croatian (6) 6
Swedish (6) 6
Serbian (5) 5
Lithuanian (4) 4
Norwegian (4) 4
Finnish (3) 3
Afrikaans (2) 2
Bosnian (2) 2
Arabic (1) 1
Icelandic (1) 1
Indonesian (1) 1
Latvian (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of hospital infection, ISSN 0195-6701, 1980
Journal
Journal
Hospital infection control, ISSN 0098-180X
Journal
Clinical infectious diseases, ISSN 1058-4838, 9/2012, Volume 55, Issue 6, pp. 807 - 815
Objective. We compared differences in the hospital charges, length of hospital stay, and mortality between patients with healthcare- and community-associated bloodstream infections, urinary tract infections... 
Hospital costs | Hospitals | Cost estimates | Antimicrobials | Hospital admissions | Urinary tract infections | Infections | Censorship | ARTICLES AND COMMENTARIES | Staphylococcus aureus | Length of stay | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Cross Infection - economics | Community-Acquired Infections - epidemiology | Length of Stay - economics | Urinary Tract Infections - mortality | Humans | Middle Aged | Cross Infection - mortality | Drug Resistance, Bacterial | Bacteremia - mortality | Male | Urinary Tract Infections - economics | Bacteremia - economics | Pneumonia, Bacterial - economics | Case-Control Studies | Bacteremia - microbiology | Hospital Charges - statistics & numerical data | Pneumonia, Bacterial - mortality | Aged, 80 and over | Adult | Female | Urinary Tract Infections - microbiology | Retrospective Studies | Bacterial Infections - microbiology | Length of Stay - statistics & numerical data | Cross Infection - epidemiology | Databases, Factual | Community-Acquired Infections - mortality | Pneumonia, Bacterial - microbiology | Bacterial Infections - economics | Community-Acquired Infections - economics | Pneumonia, Bacterial - epidemiology | Urinary Tract Infections - epidemiology | Health Care Costs | Cross Infection - microbiology | Bacterial Infections - epidemiology | Survival Analysis | Bacteremia - epidemiology | New York City - epidemiology | Aged | Community-Acquired Infections - microbiology | Bacterial Infections - mortality | Infection | Blood-borne diseases | Care and treatment | Economic aspects | Research | Drug resistance | Medical care, Cost of | Hospitalization | Health care expenditures | Bacterial infections | Incentives | Mortality | Index Medicus | and Commentaries
Journal Article
PloS one, ISSN 1932-6203, 08/2012, Volume 7, Issue 8, pp. e43666 - e43666
Background: In Madagascar, very little is known about the etiology and prevalence of acute respiratory infections (ARIs... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Madagascar - epidemiology | Virus Diseases - epidemiology | Coinfection | Community-Acquired Infections - etiology | Prevalence | Prospective Studies | Respiratory Syncytial Virus Infections - epidemiology | Viruses - genetics | Community-Acquired Infections - epidemiology | Humans | Child, Preschool | Fever - epidemiology | Paramyxoviridae Infections - epidemiology | Virus Diseases - complications | Bacterial Infections - complications | Tropical Climate | Cough - epidemiology | Polymerase Chain Reaction | Bacteria - classification | Respiratory Tract Infections - etiology | Seasons | Respiratory Syncytial Virus Infections - complications | Viruses - isolation & purification | Acute Disease | Rural Population - statistics & numerical data | Bacteria - genetics | Viruses - classification | Cough - etiology | Bacteria - isolation & purification | Paramyxoviridae Infections - complications | Bacterial Infections - epidemiology | Fever - etiology | Respiratory Tract Infections - epidemiology | Pneumonia | Malaria | Bacterial pneumonia | Development and progression | Bacteria | Diagnosis | Children | Causes and theories of causation | Health aspects | Diseases | Laboratories | Communities | Diagnostic tests | Viruses | Infections | Respiratory tract | Illnesses | Etiology | Consent | Respiratory tract diseases | Parainfluenza | Vector-borne diseases | Rural areas | Mortality | Hospitalization | Coronaviruses | Cough | Children & youth | Polymerase chain reaction | Influenza | Viral infections | Index Medicus | Respiratory Tract Infections | Madagascar | Paramyxoviridae Infections | Respiratory Syncytial Virus Infections | Fever | Life Sciences | Rural Population | Bacterial Infections | Community-Acquired Infections | Virus Diseases | Developing countries | LDCs
Journal Article
Annals of internal medicine, ISSN 0003-4819, 03/2014, Volume 160, Issue 6, pp. 389-397 - 397
Background: Since September 2012, 170 confirmed infections with Middle East respiratory syndrome coronavirus (MERS-CoV... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Community-Acquired Infections - therapy | Community-Acquired Infections - epidemiology | Humans | Middle Aged | Respiratory Insufficiency - virology | Male | Adrenal Cortex Hormones - therapeutic use | Respiratory Tract Infections - therapy | Coronavirus Infections - epidemiology | Aged, 80 and over | Coronavirus Infections - complications | Adult | Female | Community-Acquired Infections - complications | Respiratory Tract Infections - complications | Respiratory Tract Infections - virology | Cross Infection - virology | Community-Acquired Infections - virology | Saudi Arabia - epidemiology | Cross Infection - epidemiology | Length of Stay | Cross Infection - therapy | Intensive Care Units | Antiviral Agents - therapeutic use | Communicable Diseases, Emerging - therapy | Treatment Outcome | Communicable Diseases, Emerging - epidemiology | Respiratory Insufficiency - therapy | Respiration, Artificial | Syndrome | Immunoglobulins, Intravenous - therapeutic use | Coronavirus Infections - therapy | Aged | Respiratory Tract Infections - epidemiology | Communicable Diseases, Emerging - virology | Medical research | Care and treatment | Coronavirus infections | Mortality | Distribution | Medicine, Experimental | Research | Health care | Disease transmission | Kidney diseases | Blood platelets | Patients | Respiratory diseases | Index Medicus | Abridged Index Medicus
Journal Article
12. MRSA
Book
Clinical infectious diseases, ISSN 1537-6591, 09/2010, Volume 51, Issue S2, pp. S183 - S197
...) has undergone rapid evolutionary changes and epidemiologic expansion to become a major cause of nosocomial and community-acquired infections worldwide... 
Osteomyelitis | Infectious diseases | Antibiotics | Antimicrobials | Endocarditis | Abscesses | Methicillin resistant staphylococcus aureus | Infections | Staphylococcus aureus | Bacteremia | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Community-Acquired Infections - diagnosis | Staphylococcal Infections - pathology | Humans | Osteomyelitis - drug therapy | Bacteremia - microbiology | Anti-Bacterial Agents - therapeutic use | Methicillin-Resistant Staphylococcus aureus - pathogenicity | Cross Infection - pathology | Endocarditis, Bacterial - pathology | Community-Acquired Infections - drug therapy | Osteomyelitis - pathology | Endocarditis, Bacterial - microbiology | Staphylococcal Infections - microbiology | Endocarditis, Bacterial - drug therapy | Staphylococcal Infections - drug therapy | Bacteremia - drug therapy | Endocarditis, Bacterial - diagnosis | Bacteremia - diagnosis | Cross Infection - drug therapy | Staphylococcal Infections - diagnosis | Osteomyelitis - diagnosis | Community-Acquired Infections - pathology | Osteomyelitis - microbiology | Cross Infection - microbiology | Cross Infection - diagnosis | Methicillin-Resistant Staphylococcus aureus - isolation & purification | Bacteremia - pathology | Community-Acquired Infections - microbiology | Staphylococcus infections | Evolution | Nosocomial infections | Drug resistance | Epidemiology | Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 09/2006, Volume 368, Issue 9538, pp. 874 - 885
Staphylococcus aureus is a gram-positive bacterium that colonises the skin and is present in the anterior nares in about 25–30% of healthy people. 1 Dependent... 
METHICILLIN-RESISTANT | PANTON-VALENTINE LEUKOCIDIN | INTENSIVE-CARE UNITS | HOSPITAL OUTBREAK | MOLECULAR EPIDEMIOLOGY | SEQUENCE-LIKE ELEMENT | CASSETTE CHROMOSOME MEC | ANTIMICROBIAL RESISTANCE | UMCG Approved | INFECTION-CONTROL MEASURES | NOSOCOMIAL TRANSMISSION | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Staphylococcus aureus - genetics | Staphylococcal Infections - drug therapy | Prevalence | Community-Acquired Infections - epidemiology | Global Health | Staphylococcus aureus - isolation & purification | Cross Infection - physiopathology | Humans | Male | Infection Control - methods | Australia - epidemiology | Cross Infection - drug therapy | Staphylococcal Infections - epidemiology | Community-Acquired Infections - drug therapy | Drug Resistance, Multiple, Bacterial | Public Health - trends | Staphylococcal Infections - physiopathology | Community-Acquired Infections - physiopathology | Hand Disinfection - methods | Methicillin Resistance | Staphylococcus aureus - drug effects | Cross Infection - epidemiology | Control | Community-acquired infections | Development and progression | Methicillin resistance | Forecasts and trends | Staphylococcus aureus | Public health | Methods | Infection control | Drug resistance in microorganisms | Genetic aspects | Research | Health aspects | Complications and side effects | Diagnosis | Demographic aspects | Risk factors | Staphylococcus aureus infections | Clinical trials | Infections | Mathematical models | Strain | Index Medicus | Abridged Index Medicus
Journal Article